Ph-Ild

1 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

Roivant's $14 million investment in a former Bayer inhaled hypertension medication has culminated in a successful phase 2 clinical trial win.

8 sources 9 articles v 6 1h ago

\n \n \n

\n \n \n \n